Skip to main content
Fig. 6 | Trials

Fig. 6

From: Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

Fig. 6

Flow of patients in the MR CLEAN-MED—modification after the recommendation of the DSMB to stop recruiting patients for moderate-dose unfractionated heparin. Abbreviations: ASA, intravenous acetylsalicylic acid; CTA, computed tomography angiogram; UFH, intravenous unfractionated heparin; EVT, endovascular treatment; LD, low dose; MD, moderate dose; MRI, magnetic resonance imaging; MRA, magnetic resonance angiography; NCCT, non-contrast computed tomography; NIHSS, National Institutes of Health Stroke Scale. Captions: *Only to be performed if imaging at 24 hour was acquired with CT; **Blood sample drawn only in case of regular outpatient clinic appointment within 2-6 months after intervention

Back to article page

Trials

ISSN: 1745-6215